Tonix Pharmaceuticals Holding (TNXP) Non Operating Income (2020 - 2025)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Non Operating Income came in at $943000.0 in Q2 2025, up 94200.0% year-on-year from N/an in Q2 2024, and up 94200.0% quarter-over-quarter from $1000.0 in Q2 2024.
Tonix Pharmaceuticals Holding (TNXP) Non Operating Income (2020 - 2025) Analysis & Trends
Tonix Pharmaceuticals Holding's Non Operating Income history runs 4 years deep, the most recent figure standing at $943000.0 for Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.58 Bn | 466.79 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 55.80 Bn | 50.61 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Tonix Pharmaceuticals Holding | 141.94 Mn | 141.94 Mn | 5.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 943,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2021 | 83,000.00 |
| Mar 31, 2020 | 24,000.00 |